Follow Us
© 2026 Arizent. All rights reserved.
Stephanie Schomer is the editor-in-chief of Employee Benefit News. She was most recently the deputy editor of Entrepreneur magazine and previously held positions at Entertainment Weekly, … Read full bio
For reprint and licensing requests for this article, click here.
Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.
The health and welfare leader and 2026 Excellence in Benefits honoree is guiding the bank in navigating them all.
Metabolism-management drugs and hormone therapy are growing in popularity, but women need expert clinical oversight in conjunction with medication access.
As more Americans turn to GLP-1 medications for weight loss, employers are weighing the benefits of coverage against rising healthcare expenses and long-term costs.
As healthcare costs continue climbing, employers are exploring new funding models, cost-containment strategies, and benefits approaches to better manage spending.
